Heparan sulfate in the stone matrix and its inhibitory effect on calcium oxalate crystallization
Heparan sulfate in the stone matrix and its inhibitory effect on calcium oxalate crystallization
复制标题
结石基质中的硫酸乙酰肝素及其对草酸钙结晶的抑制作用
DOI:
10.1007/bf00590035
复制
发表时间:
1993
影响因子:
--
通讯作者:
T. Sonoda
中科院分区:
文献类型:
--
作者:
S. Yamaguchi;T. Yoshioka;M. Utsunomiya;T. Koide;M. Osafune;A. Okuyama;T. Sonoda
SummaryThe nature of the soluble stone matrix and its possible role in urinary stone formation was studied. For this purpose we performed two-dimensional cellulose acetate membrane electrophoresis of the glycosaminoglycans (GAGs) which were contained in the soluble stone matrix, substances adsorbed onto calcium oxalate crystals in vitro (crystal surface binding substances, CSBS) and urinary macromolecules (UMMs). The main GAG in the soluble stone matrix and CSBS was found to be heparan sulfate, whereas the UMMs contained various GAGs usually seen in urine. An inhibition assay showed the soluble stone matrix to have the strongest inhibitory activity among these macromolecular substances when inhibitory activity was expressed in terms of uronic acid concentration. It is suggested that the main GAG in the soluble stone matrix consists of heparan sulfate, which has a strong inhibitory activity on calcium oxalate crystal growth and aggregation and constitutes part of the CSBS.